Arthneeti

Citurgia Biochemicals Share Price & Earnings Call Analysis

₹102.45-0.97% today
Market cap
₹1,353 Cr
Debt to equity
0.00
52W high / low
₹212 / ₹47.4
Promoter holding
99.36%

Incorporated in 1969, Citurgia Biochemicals Ltd deals in the manufacturing and trading of citric acid.[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Citurgia Biochem rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹234 Cr3.0
240%+Flat₹3,888 Cr48.5
340%+Flat₹3,514 Cr4.3
440%+Flat₹180 Cr11.9
540%+Flat₹138 Cr15.1
620–40%Up 2%+₹1.70L Cr85.4

Sign up free to see every company in the sector ranking and track Citurgia Biochem.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of Citurgia Biochem

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Citurgia Biochem

Quarterly Results

Quarter-by-quarter operating performance

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales +0.000.000.000.000.000.000.000.000.000.000.000.000.00
Expenses +0.050.090.040.090.050.070.040.080.050.060.030.050.23
Operating Profit-0.05-0.09-0.04-0.09-0.05-0.07-0.04-0.08-0.05-0.06-0.03-0.05-0.23
OPM %
Other Income +0.000.000.000.000.000.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.060.060.050.060.060.060.050.060.060.060.050.060.06
Profit before tax-0.11-0.15-0.09-0.15-0.11-0.13-0.09-0.14-0.11-0.12-0.08-0.11-0.29
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit +-0.10-0.14-0.09-0.15-0.11-0.13-0.09-0.14-0.10-0.12-0.08-0.11-0.29
EPS in Rs-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.01-0.02

Financials of Citurgia Biochem

Profit & Loss

Annual income statement trend

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales +0.000.000.000.000.000.000.000.000.000.000.000.000.00
Expenses +0.170.180.160.100.180.240.120.370.180.210.250.200.37
Operating Profit-0.17-0.18-0.16-0.10-0.18-0.24-0.12-0.37-0.18-0.21-0.25-0.20-0.37
OPM %
Other Income +0.000.000.000.000.000.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.670.580.500.430.370.320.280.240.230.230.230.230.23
Profit before tax-0.84-0.76-0.66-0.53-0.55-0.56-0.40-0.61-0.41-0.44-0.48-0.43-0.60
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit +-0.84-0.76-0.66-0.54-0.55-0.56-0.40-0.61-0.40-0.44-0.48-0.42-0.60
EPS in Rs-0.06-0.06-0.05-0.04-0.04-0.04-0.03-0.05-0.03-0.03-0.04-0.03-0.05
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials of Citurgia Biochem

Balance Sheet

Capital structure and asset base

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital26.4226.4226.4226.4226.4226.4226.4226.4226.4226.4226.4226.4226.42
Reserves-27.59-28.35-29.01-29.55-30.10-30.66-31.06-31.67-32.08-32.51-32.99-33.41-33.75
Borrowings +4.474.494.505.156.456.486.486.496.496.556.776.836.87
Other Liabilities +7.928.599.679.9310.0510.1310.1310.3610.6010.7310.8410.9210.95
Total Liabilities11.2211.1511.5811.9512.8212.3711.9711.6011.4311.1911.0410.7610.49
Fixed Assets +4.243.663.162.732.362.041.761.521.301.070.850.620.51
CWIP0.000.000.000.000.000.000.000.000.000.000.000.000.00
Investments0.000.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets +6.987.498.429.2210.4610.3310.2110.0810.1310.1210.1910.149.98
Total Assets11.2211.1511.5811.9512.8212.3711.9711.6011.4311.1911.0410.7610.49

Financials of Citurgia Biochem

Cash Flows

Operating, investing and financing cash movement

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +0.11-0.03-0.08-0.51-1.32-0.19-0.11-0.15-0.03-0.07-0.14-0.12
Cash from Investing Activity +0.000.000.000.13-0.070.020.060.150.010.04-0.050.07
Cash from Financing Activity +0.000.000.000.651.300.030.000.010.000.060.220.06
Net Cash Flow0.11-0.03-0.080.27-0.09-0.15-0.060.01-0.010.020.030.01
Free Cash Flow0.11-0.03-0.08-0.51-1.32-0.19-0.11-0.15-0.03-0.07-0.14-0.12
CFO/OP-65%17%50%510%733%79%92%41%17%33%56%60%

Financials of Citurgia Biochem

Ratios

Working capital efficiency and return ratios

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %-22.58%-25.94%-29.53%-26.97%-22.96%-22.36%-19.61%-39.61%-39.61%-68.22%-145.45%-2,150.00%

Continue your research

Others in Chemicals & Petrochemicals this season

  • J.G.Chemicals (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd

  • Lords Chloro (Q2 FY27)

    115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against

  • Camlin Fine (Q2 FY27)

    Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27

  • Gujarat Fluoroch (Q2 FY27)

    Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv

Compare:vs Solar Industriesvs Pidilite Industriesvs SRF